Helen Mogun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Helen Mogun has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Daniel H. Solomon
Brigham and Women's Hospital
4 shared publications - Jerry Avorn
Division of Pharmacoepidemiology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA
3 shared publications - Amber Servi
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital/Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
1 shared publication - Jeffrey N. Katz
Brigham and Women's Hospital and Harvard Medical School Boston Massachusetts
1 shared publication - Jennifer M. Polinski
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA, USA
1 shared publication - M. Alan Brookhart
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Womens’ Hospital and Harvard Medical School, Suite 3030 1640 Tremont Street, Boston, MA, USA
1 shared publication
Latest Publications
- Open Access
- 23 February 2011
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 13 (1) , R32
Validation of rheumatoid arthritis diagnoses in health care utilization data
Introduction: Health care utilization databases have been increasingly used for studies of rheumatoid arthritis (RA). However, the accuracy of RA diagnoses in these data has been inconsistent. Methods: Using medical records and a standardized abstraction form, we examined the positive predictive value (PPV) of several algorithms to define RA diagnosis using claims data: A) at least two visits coded for RA (ICD-9, 714); B) at least three visits coded for RA; and C) at least two visits to a rheumatologist for RA. We also calculated the PPVs for the subgroups identified by these algorithms combined with pharmacy claims data for at least one disease-modifying anti-rheumatic drug (DMARD) prescription. Results: We invited 9,482 Medicare beneficiaries with pharmacy benefits in Pennsylvania to participate; 2% responded and consented for review of their medical records. There was no difference in characteristics between respondents and non-respondents. Using 'RA diagnosis per rheumatologists' as the gold standard, the PPVs were 55.7% for at least two claims coded for RA, 65.5% for at least three claims for RA, and 66.7% for at least two rheumatology claims for RA. The PPVs of these algorithms in patients with at least one DMARD prescription increased to 86.2%-88.9%. When fulfillment of 4 or more of the ACR RA criteria was used as the gold standard, the PPVs of the algorithms combined with at least one DMARD prescriptions were 55.6%-60.7%. Conclusions: To accurately identify RA patients in health care utilization databases, algorithms that include both diagnosis codes and DMARD prescriptions are recommended.
- 23 February 2011
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 13 (1) , R32
Open AccessValidation of rheumatoid arthritis diagnoses in health care utilization data
Introduction: Health care utilization databases have been increasingly used for studies of rheumatoid arthritis (RA). However, the accuracy of RA diagnoses in these data has been inconsistent. Methods: Using medical records and a standardized abstraction form, we examined the positive predictive value (PPV) of several algorithms to define RA diagnosis using claims data: A) at least two visits coded for RA (ICD-9, 714); B) at least three visits coded for RA; and C) at least two visits to a rheumatologist for RA. We also calculated the PPVs for the subgroups identified by these algorithms combined with pharmacy claims data for at least one disease-modifying anti-rheumatic drug (DMARD) prescription. Results: We invited 9,482 Medicare beneficiaries with pharmacy benefits in Pennsylvania to participate; 2% responded and consented for review of their medical records. There was no difference in characteristics between respondents and non-respondents. Using 'RA diagnosis per rheumatologists' as the gold standard, the PPVs were 55.7% for at least two claims coded for RA, 65.5% for at least three claims for RA, and 66.7% for at least two rheumatology claims for RA. The PPVs of these algorithms in patients with at least one DMARD prescription increased to 86.2%-88.9%. When fulfillment of 4 or more of the ACR RA criteria was used as the gold standard, the PPVs of the algorithms combined with at least one DMARD prescriptions were 55.6%-60.7%. Conclusions: To accurately identify RA patients in health care utilization databases, algorithms that include both diagnosis codes and DMARD prescriptions are recommended.
- Open Access
- 26 May 2008
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 168 (10) , 1111-1115
Osteoporosis Medication Use in Nursing Home Patients With Fractures in 1 US State
Osteoporosis has been reported in 80% of all nursing home (NH) residents.1 Prospective cohort studies have reported rates of 3.7 to 5.0 hip fractures per 100 NH residents per year, a risk 2.5- to 10-times greater than in community-dwelling elderly subjects.2-4 Fractures significantly increase morbidity5 and health care utilization in NH residents.6 In one study of 1427 female NH residents, those who had a fracture were hospitalized 15 times more often in the month following the fracture compared with those who did not have a fracture, and this risk persisted 3 to 12 months after fracture.6
- 26 May 2008
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 168 (10) , 1111-1115
Open AccessOsteoporosis Medication Use in Nursing Home Patients With Fractures in 1 US State
Osteoporosis has been reported in 80% of all nursing home (NH) residents.1 Prospective cohort studies have reported rates of 3.7 to 5.0 hip fractures per 100 NH residents per year, a risk 2.5- to 10-times greater than in community-dwelling elderly subjects.2-4 Fractures significantly increase morbidity5 and health care utilization in NH residents.6 In one study of 1427 female NH residents, those who had a fracture were hospitalized 15 times more often in the month following the fracture compared with those who did not have a fracture, and this risk persisted 3 to 12 months after fracture.6